Zydena’s once-daily-dosing is effective

Published: 2009-11-23 06:58:00
Updated: 2009-11-23 06:58:00
Dong-A Pharmaceutical Co. says it has completed a 240 Korean patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).

Following a 4-week non-drug baseline period, 240 men with ED of broad etiology and se...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.